Coya Therapeutics, Inc. - Common Stock — Bilancio Trimestrale (NASDAQ:COYA) | MetaTrader

Apri il grafico completo Full chart

Notizie

Coya Therapeutics ottiene la Fast Track FDA per il trattamento dell’ALS

Il fondatore di Coya Therapeutics si dimette, nominato nuovo direttore

3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts - TipRanks.com

Coya Therapeutics, Inc. (COYA) Upgraded to Buy: What Does It Mean for the Stock?

H.C. Wainwright conferma il rating Buy su Coya Therapeutics con target di $18

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target

Coya Therapeutics ottiene 11,1 milioni di dollari tramite posizionamento privato

Coya Therapeutics secures $11.1 million in private placement

Coya Therapeutics advances ALS and FTD clinical trials in 2026

H.C. Wainwright conferma rating Buy su Coya Therapeutics con target a $18

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18

Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)